About Formosa Pharmaceuticals
Board of Directors
Dr. Hong-Jen Chang currently serves as Chairman and CEO of YFY Biotech Management Company. Prior to joining the YFY Group, Dr. Chang gained extensive experience in the health care sectors. During his 16-year service with the government, he held several key positions in the Taiwanese Ministry of Health and Welfare and served as President & CEO of Bureau of National Health Insurance (BNHI) and Director General of Center of Disease Control.
Dr. Chang received his medical degree from National Yang-Ming Medical College. He also holds Masters degree in Public Health from National Taiwan University, and Master of Science in Health Policy and Management from Harvard School of Public Health.
Dr. Jo Shen is the Co-Founder for ScinoPharm Taiwan, Ltd., and served as its Chief Executive Officer and President for 17 years. Dr. Shen has more than 40 years of experience in the industry regarding international pharmaceutical executive. Prior to ScinoPharm, she worked with Syntex and Monsanto. Dr. Shen holds a Ph.D. in Physical Chemistry from Lehigh University, a M.S. in Inorganic Chemistry from the University of Iowa and a B.S. in Chemical Engineering from National Taiwan University. Dr. Shen is a Venture Partner at Vivo Capital, LLC since 2016.
Founded in 2020, CDIB Capital Healthcare Ventures II follows the Taiwan+ investment strategy, makes good use of the advantages of Taiwan’s talents and supporting facilities. Cooperate with Taiwanese and Chinese entrepreneurs or enterprises with successful business experience, connect domestic and foreign resources and business opportunities, and invest in biotechnology, medicine, medical technology, digital healthcare, other biomedical health and service-related industries.
Dr. Kang is a Professor at the Institute of Food Safety and Health Risk Assessment at National Yang-Ming Chiao Tung University. Dr. Kang was the Director of the General Office of Food Safety and National Laboratories of Foods and Drugs in the Department of Health of Taiwan, Dr. Kang has rich experience in biotechnology.